Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Dexmedetomidine for Sedation in AF Ablation
NCT05864404Unknown
- Sponsor
- Yonsei University
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in Atrial fibrillation (AFib) (2 arms), sponsored by Yonsei University. Primary endpoint: Patient Satisfaction Levels. Status: unknown.
02
Drugs
remimazolam
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05864404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05864404.